Overview

Curie.Bio helps founders discover and develop important new medicines by investing in existing biotech companies, creating focused spinouts, and building ventures from scratch. It deploys about $1B for seed and Series A rounds and works closely with a 100-person team that provides hands-on, operational guidance to reach critical development milestones efficiently. The firm combines a large fund with deep pharma expertise and a three-pronged approach—investing, spinning out programs, and building companies—to accelerate progress beyond what money alone can achieve. Its goal is to bring new medicines to patients by helping founders reach key milestones in a capital-efficient way.